| SKU | ISG001944 |
| Brand | Bladogra |
| Categories | Medication & Treatments |
| Concentrations | 50 Mg |
| Shop by Concerns | Incontinence |
| Gender | Unisex |
| Shop By Goals | Overnight protection |
| Ingredient | Mirabegron |
| UPC | 6223003205867 |
| Product Form | Tablets |
| Specialty | Clinically Tested Prescription only |
| Sub Categories | Urinary Tract Medications |
| Unit Count | 30 Tablets |
| Warning | Keep Out of Reach of Children May increase blood pressure Not recommended in uncontrolled hypertension Risk of urinary retention Use under medical supervision only |
Bladogra 50 Mg 30 Tablets
Description:
Bladogra 50 mg 30 tablets (Bladogra XR 50 mg film-coated tablets) is a prescription medicine containing mirabegron, a beta-3 adrenergic receptor agonist used for the management of overactive bladder (OAB). It helps relax the detrusor muscle of the bladder, increasing bladder capacity and reducing episodes of urgency, urinary frequency, and urge urinary incontinence. Bladogra is an oral medication designed for adults who suffer from bothersome urinary symptoms and may not tolerate or respond adequately to antimuscarinic medications. It is produced by Multi-Apex and is intended for long-term symptom control under medical supervision.
Indications:
- Management of overactive bladder (OAB) in adults.
- Relief of symptoms associated with OAB, including urinary urgency.
- Treatment of urge urinary incontinence (sudden, strong need to urinate with involuntary leakage).
- Reduction of increased daytime and nighttime urinary frequency.
- May be used as an alternative in patients who cannot tolerate antimuscarinic agents due to anticholinergic side effects, as directed by a physician.
Active Ingredients / Key Components:
- Mirabegron – 50 mg per film-coated tablet.
- Other inactive ingredients/excipients: Not specified in the available product information. Please refer to the package leaflet for the complete list of excipients.
Dosage & Administration / How to Use:
- Bladogra is an oral prescription medicine and should be used exactly as directed by your physician.
- Typical adult dose for overactive bladder: 50 mg mirabegron once daily (1 tablet), swallowed whole with water. Do not crush, chew, or split the film-coated tablet, as it is an extended-release (XR) formulation.
- Can be taken with or without food, preferably at the same time each day to maintain consistent blood levels.
- Your doctor may adjust the dose or avoid use in patients with severe renal or hepatic impairment; follow medical advice strictly.
- If you miss a dose, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose and resume your regular schedule. Do not take a double dose to make up for a missed one.
- Do not stop taking Bladogra without consulting your doctor, even if symptoms improve, as symptoms may return.
Clinical Benefits:
- Helps reduce episodes of urinary urgency and the sudden strong need to urinate.
- Decreases urge urinary incontinence, helping to reduce involuntary urine leakage and accidents.
- Lowers urinary frequency, allowing longer intervals between bathroom visits during day and night.
- Improves bladder storage capacity by relaxing the detrusor muscle via beta-3 adrenergic receptor stimulation.
- May offer an alternative treatment option for patients who do not tolerate antimuscarinic drugs due to dry mouth, constipation, or other anticholinergic side effects.
- Supports better quality of life, confidence, and daily functioning for individuals with overactive bladder symptoms.
Warnings & Contraindications:
- Use only under medical supervision. Bladogra (mirabegron) is a prescription medication.
- Contraindicated in patients with known hypersensitivity to mirabegron or any component of the formulation.
- Use with caution in patients with severe uncontrolled hypertension; mirabegron may increase blood pressure.
- Caution in patients with a history of bladder outlet obstruction or those taking antimuscarinic drugs concurrently, due to risk of urinary retention.
- Use with caution in patients with moderate to severe renal impairment or hepatic impairment; dose adjustment or avoidance may be required as per physician guidance.
- Consult your doctor before use if you have cardiovascular disease, arrhythmias, prolonged QT interval, kidney disease, liver disease, or are taking other medications that may interact.
- Pregnancy and breastfeeding: Use only if clearly needed and prescribed by a physician. Safety data in pregnancy and lactation are limited.
- Not recommended for use in children unless specifically prescribed by a pediatric specialist.
- Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as hypertension, heart disease, liver disease, or kidney disease.
- Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
- Keep out of reach of children.
- Do not exceed the prescribed dose. In case of overdose, seek medical attention immediately.
Side Effects:
- Common side effects may include increased blood pressure, headache, dry mouth, constipation, dizziness, urinary tract infections, or nasopharyngitis (cold-like symptoms).
- Less common side effects can include palpitations, tachycardia (fast heartbeat), abdominal pain, nausea, or joint pain.
- Serious but rare side effects may include severe hypertension, allergic reactions (rash, itching, swelling of face/lips/tongue, difficulty breathing), or urinary retention (inability to pass urine). Seek immediate medical attention if these occur.
- If you experience persistent or bothersome side effects, or any new or unusual symptoms, contact your doctor or pharmacist promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the package. Store at room temperature according to the manufacturer’s instructions on the leaflet.
Specifications:
- Product type: Prescription medicine for overactive bladder.
- Active ingredient strength: mirabegron 50 mg per film-coated tablet.
- Form: Extended-release film-coated tablets (oral use).
- Pack size: 30 tablets per pack.
- Intended users: Adult men and women with symptoms of overactive bladder, as prescribed by a healthcare professional.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

